| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparison of treatment results for recurrent malignant gliomas
|
Nieder, C.
|
|
2000
|
|
6 |
p. 397-409
13 p.
|
artikel
|
| 2 |
Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer
|
Maduro, J.H
|
|
2003
|
|
6 |
p. 471-488
18 p.
|
artikel
|
| 3 |
Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma
|
Hamilton, David A
|
|
2006
|
|
6 |
p. 483-486
4 p.
|
artikel
|
| 4 |
Adding interferon- α to octreotide slows tumour progression compared with octreotide alone but evidence is lacking for improved survival in people with disseminated midgut carcinoid tumours
|
Pape, Ulrich-Frank
|
|
2003
|
|
6 |
p. 565-569
5 p.
|
artikel
|
| 5 |
Addressing the unmet need in lung cancer: The potential of immuno-oncology
|
Scagliotti, G.V.
|
|
2015
|
|
6 |
p. 465-475
11 p.
|
artikel
|
| 6 |
Adjuvant immunotherapy for non-small cell lung cancer
|
Tucker, Zachary C.G.
|
|
2012
|
|
6 |
p. 650-661
12 p.
|
artikel
|
| 7 |
Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/ neu -overexpressing breast cancer: A systematic review
|
Madarnas, Yolanda
|
|
2008
|
|
6 |
p. 539-557
19 p.
|
artikel
|
| 8 |
Adjuvant UFT therapy does not increase survival in people with resected stage 1 non-small cell lung cancer
|
Stewart, Lesley
|
|
2005
|
|
6 |
p. 487-490
4 p.
|
artikel
|
| 9 |
Advances in the treatment of non-small cell lung cancer
|
Saijo, Nagahiro
|
|
2008
|
|
6 |
p. 521-526
6 p.
|
artikel
|
| 10 |
Alertness, cognition and morphine in patients with advanced cancer
|
Clemons, Mark
|
|
1996
|
|
6 |
p. 451-468
18 p.
|
artikel
|
| 11 |
A literature review of the association between diffusion-weighted MRI derived apparent diffusion coefficient and tumour aggressiveness in pelvic cancer
|
Bollineni, V.R.
|
|
2015
|
|
6 |
p. 496-502
7 p.
|
artikel
|
| 12 |
Allogeneic stem cell transplantation for the non-Hodgkin’s lymphomas and Hodgkin’s disease
|
Hale, G.A.
|
|
2000
|
|
6 |
p. 411-427
17 p.
|
artikel
|
| 13 |
Angiogenesis and anti-angiogenesis in hepatocellular carcinoma
|
Ribatti, Domenico
|
|
2006
|
|
6 |
p. 437-444
8 p.
|
artikel
|
| 14 |
Antiresorptive therapies in oncology and their effects on cancer progression
|
Bundred, Nigel
|
|
2012
|
|
6 |
p. 776-786
11 p.
|
artikel
|
| 15 |
Antiresorptive treatment options and bone health in cancer patients—safety profiles and clinical considerations
|
Hadji, Peyman
|
|
2012
|
|
6 |
p. 815-824
10 p.
|
artikel
|
| 16 |
Application of the area under the curve of carboplatin in predicting toxicity and efficacy
|
de Lemos, Mário L.
|
|
1998
|
|
6 |
p. 407-414
8 p.
|
artikel
|
| 17 |
A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension
|
Cavuoto, Paul
|
|
2012
|
|
6 |
p. 726-736
11 p.
|
artikel
|
| 18 |
Arsenical-based cancer drugs
|
Dilda, Pierre J.
|
|
2007
|
|
6 |
p. 542-564
23 p.
|
artikel
|
| 19 |
Articles to appear in forthcoming issues
|
|
|
2003
|
|
6 |
p. 573-
1 p.
|
artikel
|
| 20 |
Articles to appear in forthcoming issues
|
|
|
2002
|
|
6 |
p. 335-
1 p.
|
artikel
|
| 21 |
Articles to appear in forthcoming issues
|
|
|
2004
|
|
6 |
p. 597-
1 p.
|
artikel
|
| 22 |
Articles to appear in forthcoming issues of Cancer Treatment Reviews
|
|
|
1995
|
|
6 |
p. 577-
1 p.
|
artikel
|
| 23 |
Articles to appear in forthcoming issues of Cancer Treatment Reviews
|
|
|
2000
|
|
6 |
p. 463-
1 p.
|
artikel
|
| 24 |
Articles to appear in forthcoming issues of Cancer Treatment Reviews
|
|
|
1996
|
|
6 |
p. 469-
1 p.
|
artikel
|
| 25 |
Articles to appear in forthcoming issues of Cancer Treatment Reviews
|
|
|
1998
|
|
6 |
p. 433-
1 p.
|
artikel
|
| 26 |
Articles to appear in forthcoming issues of Cancer Treatment Reviews
|
|
|
2001
|
|
6 |
p. 403-
1 p.
|
artikel
|
| 27 |
Assessment of quality of life in advanced non-small-cell lung cancer: An overview of recent randomized trials
|
Saad, Everardo D.
|
|
2012
|
|
6 |
p. 807-814
8 p.
|
artikel
|
| 28 |
Assessment of tumor response in malignant pleural mesothelioma
|
Ceresoli, Giovanni L.
|
|
2007
|
|
6 |
p. 533-541
9 p.
|
artikel
|
| 29 |
A systematic review of salvage therapy to patients with metastatic colorectal cancer previously treated with fluorouracil, oxaliplatin and irinotecan +/− targeted therapy
|
Nielsen, Dorte Lisbet
|
|
2014
|
|
6 |
p. 701-715
15 p.
|
artikel
|
| 30 |
Author Index
|
|
|
2001
|
|
6 |
p. 4-5
2 p.
|
artikel
|
| 31 |
Autologous tumour cell vaccine may reduce risk of tumour progression in people with primary renal cell carcinoma
|
Coppin, Chris
|
|
2004
|
|
6 |
p. 589-593
5 p.
|
artikel
|
| 32 |
Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies
|
De Bari, Berardino
|
|
2015
|
|
6 |
p. 511-518
8 p.
|
artikel
|
| 33 |
Benefits of axillary radiotherapy unclear in women with early stage breast cancer undergoing conservative breast surgery without axillary dissection
|
Sanuki-Fujimoto, Naoko
|
|
2005
|
|
6 |
p. 496-500
5 p.
|
artikel
|
| 34 |
Beyond EGFR TKI in EGFR-mutant Non-Small Cell Lung Cancer patients: Main challenges still to be overcome
|
Remon, J.
|
|
2014
|
|
6 |
p. 723-729
7 p.
|
artikel
|
| 35 |
Biologic rationale and clinical activity of mTOR inhibitors in gynecological cancer
|
Diaz-Padilla, Ivan
|
|
2012
|
|
6 |
p. 767-775
9 p.
|
artikel
|
| 36 |
Biomarkers in the development of anti-angiogenic therapies for ovarian cancer
|
Raja, Fharat A.
|
|
2012
|
|
6 |
p. 662-672
11 p.
|
artikel
|
| 37 |
Biomarkers of regimen-related mucosal injury
|
Gibson, Rachel J.
|
|
2011
|
|
6 |
p. 487-493
7 p.
|
artikel
|
| 38 |
Bone health in postmenopausal women with early breast cancer: How protective is tamoxifen?
|
Ding, Hongliu
|
|
2007
|
|
6 |
p. 506-513
8 p.
|
artikel
|
| 39 |
Brachytherapy in the management of breast cancer: a review
|
Pieters, B.R.
|
|
1995
|
|
6 |
p. 527-539
13 p.
|
artikel
|
| 40 |
Breakthrough pain in cancer patients: Pathophysiology and treatment
|
Mercadante, S.
|
|
1998
|
|
6 |
p. 425-432
8 p.
|
artikel
|
| 41 |
Calendar
|
|
|
2003
|
|
6 |
p. 575-
1 p.
|
artikel
|
| 42 |
Calendar
|
|
|
1998
|
|
6 |
p. 435-440
6 p.
|
artikel
|
| 43 |
Calendar
|
|
|
2000
|
|
6 |
p. 465-466
2 p.
|
artikel
|
| 44 |
Calendar
|
|
|
2001
|
|
6 |
p. 405-
1 p.
|
artikel
|
| 45 |
Cancer stem cells: In the line of fire
|
Alison, Malcolm R.
|
|
2012
|
|
6 |
p. 589-598
10 p.
|
artikel
|
| 46 |
Cancer surgery: the last 25 years
|
Bremers, A.J.A.
|
|
1999
|
|
6 |
p. 333-353
21 p.
|
artikel
|
| 47 |
Cancer treatment-induced bone loss in premenopausal women: A need for therapeutic intervention?
|
Hadji, P.
|
|
2012
|
|
6 |
p. 798-806
9 p.
|
artikel
|
| 48 |
Cancer treatment: the last 25 years
|
McVie, J.Gordon
|
|
1999
|
|
6 |
p. 323-331
9 p.
|
artikel
|
| 49 |
Can lung cancer stem cells be targeted for therapies?
|
Wu, Xiaodan
|
|
2012
|
|
6 |
p. 580-588
9 p.
|
artikel
|
| 50 |
Can we better manage Unfit older cancer patients?
|
Monfardini, Silvio
|
|
2009
|
|
6 |
p. 485-486
2 p.
|
artikel
|
| 51 |
Cardiovascular effects of breast cancer radiotherapy
|
Senkus-Konefka, Elżbieta
|
|
2007
|
|
6 |
p. 578-593
16 p.
|
artikel
|
| 52 |
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
|
Izumi, Hiroto
|
|
2003
|
|
6 |
p. 541-549
9 p.
|
artikel
|
| 53 |
Chemo-immunotherapy and chemo-adoptive immunotherapy of cancer
|
Gomez, G.G
|
|
2001
|
|
6 |
p. 375-402
28 p.
|
artikel
|
| 54 |
Chemotherapy for operable and advanced colorectal cancer
|
Aschele, Carlo
|
|
2009
|
|
6 |
p. 509-516
8 p.
|
artikel
|
| 55 |
Classification of anticancer drugs—a new system based on therapeutic targets
|
Espinosa, Enrique
|
|
2003
|
|
6 |
p. 515-523
9 p.
|
artikel
|
| 56 |
Cognitive dysfunctions in elderly cancer patients: A new challenge for oncologists
|
Lange, Marie
|
|
2014
|
|
6 |
p. 810-817
8 p.
|
artikel
|
| 57 |
Colorectal cancer screening in elderly patients: When should be more useful?
|
Pasetto, Lara Maria
|
|
2007
|
|
6 |
p. 528-532
5 p.
|
artikel
|
| 58 |
Combating melanoma: The use of photodynamic therapy as a novel, adjuvant therapeutic tool
|
Davids, L.M.
|
|
2011
|
|
6 |
p. 465-475
11 p.
|
artikel
|
| 59 |
Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer
|
Meijerman, Irma
|
|
2008
|
|
6 |
p. 505-520
16 p.
|
artikel
|
| 60 |
Combined BRAF and MEK inhibition for the treatment of BRAF-mutated metastatic melanoma
|
Queirolo, Paola
|
|
2015
|
|
6 |
p. 519-526
8 p.
|
artikel
|
| 61 |
Comparison of weekly versus every 3 weeks paclitaxel in the treatment of advanced solid tumors: A meta-analysis
|
Huang, Ta-Chen
|
|
2012
|
|
6 |
p. 613-617
5 p.
|
artikel
|
| 62 |
Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide
|
Estlin, E.J.
|
|
2001
|
|
6 |
p. 339-350
12 p.
|
artikel
|
| 63 |
Continuing therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of methotrexate, 6-mercaptopurine and 6-thioguanine
|
Estlin, E.J
|
|
2001
|
|
6 |
p. 351-363
13 p.
|
artikel
|
| 64 |
Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials
|
Mackey, John R.
|
|
2012
|
|
6 |
p. 673-688
16 p.
|
artikel
|
| 65 |
Controversies in the adjuvant systemic therapy of endocrine-non-responsive breast cancer
|
Cardoso, Fatima
|
|
2002
|
|
6 |
p. 275-290
16 p.
|
artikel
|
| 66 |
Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer
|
Brechbiel, Jillian
|
|
2014
|
|
6 |
p. 750-759
10 p.
|
artikel
|
| 67 |
Current state of knowledge regarding the use of antiangiogenic agents with radiation therapy
|
Mazeron, Renaud
|
|
2011
|
|
6 |
p. 476-486
11 p.
|
artikel
|
| 68 |
Current status of excision repair cross complementing-group 1 (ERCC1) in cancer
|
Gossage, Lucy
|
|
2007
|
|
6 |
p. 565-577
13 p.
|
artikel
|
| 69 |
Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors
|
Araujo, John
|
|
2010
|
|
6 |
p. 492-500
9 p.
|
artikel
|
| 70 |
Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: A systematic review
|
Verbrugghe, M.
|
|
2013
|
|
6 |
p. 610-621
12 p.
|
artikel
|
| 71 |
Developing a theoretical framework to illustrate associations among patient satisfaction, body image and quality of life for women undergoing breast reconstruction
|
Fingeret, Michelle Cororve
|
|
2013
|
|
6 |
p. 673-681
9 p.
|
artikel
|
| 72 |
Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM×anti-CD3) as a targeted cancer immunotherapy
|
Seimetz, Diane
|
|
2010
|
|
6 |
p. 458-467
10 p.
|
artikel
|
| 73 |
Diffuse malignant peritoneal mesothelioma – An update on treatment
|
Mirarabshahii, Peyman
|
|
2012
|
|
6 |
p. 605-612
8 p.
|
artikel
|
| 74 |
Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer
|
van de Ven, S.
|
|
2011
|
|
6 |
p. 422-430
9 p.
|
artikel
|
| 75 |
DNA-based drug interactions of cisplatin
|
Crul, M
|
|
2002
|
|
6 |
p. 291-303
13 p.
|
artikel
|
| 76 |
DNA repair and cancer stem-like cells – Potential partners in glioma drug resistance?
|
Johannessen, Tor-Christian Aase
|
|
2008
|
|
6 |
p. 558-567
10 p.
|
artikel
|
| 77 |
Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis
|
Vale, Claire L.
|
|
2012
|
|
6 |
p. 618-625
8 p.
|
artikel
|
| 78 |
Dose adjustment and supportive care before and during treatment
|
Brunello, Antonella
|
|
2009
|
|
6 |
p. 493-498
6 p.
|
artikel
|
| 79 |
Editorial
|
|
|
1999
|
|
6 |
p. 321-
1 p.
|
artikel
|
| 80 |
Editorial Board
|
|
|
2009
|
|
6 |
p. IFC-
1 p.
|
artikel
|
| 81 |
Editorial Board
|
|
|
2014
|
|
6 |
p. IFC-
1 p.
|
artikel
|
| 82 |
Editorial Board
|
|
|
2010
|
|
6 |
p. IFC-
1 p.
|
artikel
|
| 83 |
Editorial board
|
|
|
2003
|
|
6 |
p. IFC-
1 p.
|
artikel
|
| 84 |
Editorial Board
|
|
|
2002
|
|
6 |
p. i-
1 p.
|
artikel
|
| 85 |
Editorial board
|
|
|
2005
|
|
6 |
p. CO2-
1 p.
|
artikel
|
| 86 |
Editorial board
|
|
|
2004
|
|
6 |
p. IFC-
1 p.
|
artikel
|
| 87 |
Editorial board
|
|
|
2006
|
|
6 |
p. CO2-
1 p.
|
artikel
|
| 88 |
Editorial board
|
|
|
2008
|
|
6 |
p. IFC-
1 p.
|
artikel
|
| 89 |
Editorial board
|
|
|
2007
|
|
6 |
p. IFC-
1 p.
|
artikel
|
| 90 |
Editorial Board
|
|
|
2015
|
|
6 |
p. IFC-
1 p.
|
artikel
|
| 91 |
Editorial Board
|
|
|
2012
|
|
6 |
p. IFC-
1 p.
|
artikel
|
| 92 |
Editorial Board
|
|
|
2013
|
|
6 |
p. IFC-
1 p.
|
artikel
|
| 93 |
Editorial Board
|
|
|
2011
|
|
6 |
p. IFC-
1 p.
|
artikel
|
| 94 |
Effect of inhibition of the FGFR–MAPK signaling pathway on the development of ocular toxicities
|
van der Noll, Ruud
|
|
2013
|
|
6 |
p. 664-672
9 p.
|
artikel
|
| 95 |
Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies
|
Okroj, Marcin
|
|
2013
|
|
6 |
p. 632-639
8 p.
|
artikel
|
| 96 |
Effects of adjuvant chemotherapy on the natural history and likelihood of therapeutic efficacy in advanced breast cancer patients: a critical literature review
|
Alexandre, Jérôme
|
|
1998
|
|
6 |
p. 393-406
14 p.
|
artikel
|
| 97 |
Effects of exercise in patients treated with stem cell transplantation for a hematologic malignancy: A systematic review and meta-analysis
|
Persoon, Saskia
|
|
2013
|
|
6 |
p. 682-690
9 p.
|
artikel
|
| 98 |
Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment
|
Yang, Feng
|
|
2012
|
|
6 |
p. 566-579
14 p.
|
artikel
|
| 99 |
Emerging roles of PDGF-D in EMT progression during tumorigenesis
|
Wu, Qiong
|
|
2013
|
|
6 |
p. 640-646
7 p.
|
artikel
|
| 100 |
Endothelial cell effects of cytotoxics: balance between desired and unwanted effects
|
de Vos, F.Y.F.L.
|
|
2004
|
|
6 |
p. 495-513
19 p.
|
artikel
|
| 101 |
Epithelial–mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact
|
Foroni, Chiara
|
|
2012
|
|
6 |
p. 689-697
9 p.
|
artikel
|
| 102 |
Epstein-Barr virus-targeted immunotherapy for nasopharyngeal carcinoma
|
Masmoudi, Amine
|
|
2007
|
|
6 |
p. 499-505
7 p.
|
artikel
|
| 103 |
Evidence-based oncology mitomycin C provides little additional benefit in the treatment of carcinoma of unknown primary site
|
Dowell, Jonathan E
|
|
2003
|
|
6 |
p. 561-563
3 p.
|
artikel
|
| 104 |
Evolution of carfilzomib dose and schedule in patients with multiple myeloma: A historical overview
|
Jakubowiak, Andrzej J.
|
|
2014
|
|
6 |
p. 781-790
10 p.
|
artikel
|
| 105 |
FGFR as potential target in the treatment of squamous non small cell lung cancer
|
Tiseo, Marcello
|
|
2015
|
|
6 |
p. 527-539
13 p.
|
artikel
|
| 106 |
Gene-expression profiles, tumor microenvironment, and cancer stem cells in breast cancer: Latest advances towards an integrated approach
|
Vera-Ramirez, Laura
|
|
2010
|
|
6 |
p. 477-484
8 p.
|
artikel
|
| 107 |
Gene profiling in breast cancer: Time to move forward
|
Espinosa, Enrique
|
|
2011
|
|
6 |
p. 416-421
6 p.
|
artikel
|
| 108 |
Gonadotropin-releasing hormone receptors as molecular therapeutic targets in prostate cancer: Current options and emerging strategies
|
Limonta, Patrizia
|
|
2013
|
|
6 |
p. 647-663
17 p.
|
artikel
|
| 109 |
HER2 aberrations in cancer: Implications for therapy
|
Yan, Min
|
|
2014
|
|
6 |
p. 770-780
11 p.
|
artikel
|
| 110 |
Hereditary nonpolyposis colorectal cancer: preventive management
|
Annie Yu, Hwei-Ju
|
|
2003
|
|
6 |
p. 461-470
10 p.
|
artikel
|
| 111 |
HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials
|
Dent, Susan
|
|
2013
|
|
6 |
p. 622-631
10 p.
|
artikel
|
| 112 |
High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin’s lymphoma
|
|
|
2003
|
|
6 |
p. 555-559
5 p.
|
artikel
|
| 113 |
High-quality evidence in oncology from 17 February to 7 April 2005: A summary
|
|
|
2005
|
|
6 |
p. 501-505
5 p.
|
artikel
|
| 114 |
High-quality evidence in oncology from 17th February to 13th April 2004: a summary
|
|
|
2004
|
|
6 |
p. 595-596
2 p.
|
artikel
|
| 115 |
Immunotherapy: the last 25 years
|
Plunkett, T.A.
|
|
1999
|
|
6 |
p. 355-363
9 p.
|
artikel
|
| 116 |
Index
|
|
|
1996
|
|
6 |
p. I-III
nvt p.
|
artikel
|
| 117 |
Index to volume 21
|
|
|
1995
|
|
6 |
p. 579-582
4 p.
|
artikel
|
| 118 |
Index to volume 24
|
|
|
1998
|
|
6 |
p. i-iii
nvt p.
|
artikel
|
| 119 |
Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases
|
Zimmermann, Stefan
|
|
2014
|
|
6 |
p. 716-722
7 p.
|
artikel
|
| 120 |
Infertility and pregnancy after breast cancer: Current knowledge and future perspectives
|
Mastro, Lucia Del
|
|
2006
|
|
6 |
p. 417-422
6 p.
|
artikel
|
| 121 |
Inhibitor of Apoptosis (IAP) proteins as therapeutic targets for radiosensitization of human cancers
|
Fulda, Simone
|
|
2012
|
|
6 |
p. 760-766
7 p.
|
artikel
|
| 122 |
Initial high dose chemotherapy plus autologous stem cell support improves survival outcomes compared with a standard CHOP regimen in people with higher intermediate risk aggressive lymphoma
|
Glasmacher, Axel
|
|
2004
|
|
6 |
p. 577-582
6 p.
|
artikel
|
| 123 |
Is androgen receptor targeting an emerging treatment strategy for triple negative breast cancer?
|
Anestis, Aristomenis
|
|
2015
|
|
6 |
p. 547-553
7 p.
|
artikel
|
| 124 |
Isolated limb perfusion of soft tissue sarcomas: A comprehensive review of literature
|
Seinen, Jojanneke M.
|
|
2013
|
|
6 |
p. 569-577
9 p.
|
artikel
|
| 125 |
Letter to the editors: Essentials for an updated epidemiology of laryngeal carcinoma
|
Marioni, Gino
|
|
2012
|
|
6 |
p. 559-
1 p.
|
artikel
|
| 126 |
Long-term chemotherapy-related cardiovascular morbidity
|
Meinardi, M.T.
|
|
2000
|
|
6 |
p. 429-447
19 p.
|
artikel
|
| 127 |
Long-term outcome of laparoscopic surgery for colorectal cancer: A cochrane systematic review of randomised controlled trials
|
Kuhry, Esther
|
|
2008
|
|
6 |
p. 498-504
7 p.
|
artikel
|
| 128 |
Male breast cancer
|
Gómez-Raposo, César
|
|
2010
|
|
6 |
p. 451-457
7 p.
|
artikel
|
| 129 |
Malignant mesothelioma: New insights into a rare disease
|
Remon, Jordi
|
|
2013
|
|
6 |
p. 584-591
8 p.
|
artikel
|
| 130 |
Management of fatigue in patients with cancer – A practical overview
|
Koornstra, Rutger H.T.
|
|
2014
|
|
6 |
p. 791-799
9 p.
|
artikel
|
| 131 |
Management of minor cervical cytological abnormalities: A systematic review and a meta-analysis of the literature
|
Kyrgiou, M.
|
|
2007
|
|
6 |
p. 514-520
7 p.
|
artikel
|
| 132 |
Management of primary and advanced breast cancer in older unfit patients (medical treatment)
|
Aapro, M.
|
|
2009
|
|
6 |
p. 503-508
6 p.
|
artikel
|
| 133 |
Management of the menopause in cancer survivors
|
Clemons, Mark
|
|
2002
|
|
6 |
p. 321-333
13 p.
|
artikel
|
| 134 |
Management of unfit older patients with advanced NSCLC
|
Gridelli, Cesare
|
|
2009
|
|
6 |
p. 517-521
5 p.
|
artikel
|
| 135 |
Management of unfit patients with unfavourable non-Hodgkin’s lymphomas
|
Soubeyran, Pierre
|
|
2009
|
|
6 |
p. 528-532
5 p.
|
artikel
|
| 136 |
Methionine dependency and cancer treatment
|
Cellarier, E
|
|
2003
|
|
6 |
p. 489-499
11 p.
|
artikel
|
| 137 |
Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways
|
Eroles, Pilar
|
|
2012
|
|
6 |
p. 698-707
10 p.
|
artikel
|
| 138 |
Molecular biology of breast cancer stem cells: Potential clinical applications
|
Nguyen, Nam P.
|
|
2010
|
|
6 |
p. 485-491
7 p.
|
artikel
|
| 139 |
Molecular treatment strategies and surgical reconstruction for metastatic bone diseases
|
Zou, Xuenong
|
|
2008
|
|
6 |
p. 527-538
12 p.
|
artikel
|
| 140 |
Multidimensional geriatric evaluation for older cancer patients as a clinical and research tool
|
Brunello, Antonella
|
|
2009
|
|
6 |
p. 487-492
6 p.
|
artikel
|
| 141 |
New approaches to prevent intestinal toxicity of irinotecan-based regimens
|
Alimonti, Andrea
|
|
2004
|
|
6 |
p. 555-562
8 p.
|
artikel
|
| 142 |
New molecular targets and biological therapies in sarcomas
|
Scappaticci, F.A
|
|
2001
|
|
6 |
p. 317-326
10 p.
|
artikel
|
| 143 |
New treatment developments applied to elderly patients with advanced prostate cancer
|
Mukherji, Deborah
|
|
2013
|
|
6 |
p. 578-583
6 p.
|
artikel
|
| 144 |
Nutritional support during oncologic treatment of patients with gastrointestinal cancer: Who could benefit?
|
Senesse, Pierre
|
|
2008
|
|
6 |
p. 568-575
8 p.
|
artikel
|
| 145 |
Oesophageal cancer: new developments in systemic therapy
|
Ilson, David H
|
|
2003
|
|
6 |
p. 525-532
8 p.
|
artikel
|
| 146 |
Oncological implications of hypoxia inducible factor-1α (HIF-1α) expression
|
O’Donnell, Jill L.
|
|
2006
|
|
6 |
p. 407-416
10 p.
|
artikel
|
| 147 |
Open questions in the management of mantle cell lymphoma
|
Li, Zhi-Ming
|
|
2013
|
|
6 |
p. 602-609
8 p.
|
artikel
|
| 148 |
Oral antibiotic administration and early hospital discharge is a safe and effective alternative for treatment of low-risk neutropenic fever
|
Vincent, S
|
|
2003
|
|
6 |
p. 551-554
4 p.
|
artikel
|
| 149 |
Oral/metronomic cyclophosphamide-based chemotherapy as option for patients with castration-refractory prostate cancer – Review of the literature
|
Nelius, T.
|
|
2011
|
|
6 |
p. 444-455
12 p.
|
artikel
|
| 150 |
Other important articles noted
|
|
|
2003
|
|
6 |
p. 571-572
2 p.
|
artikel
|
| 151 |
Papillary thyroid microcarcinoma: A surgical perspective
|
Sakorafas, George H.
|
|
2005
|
|
6 |
p. 423-438
16 p.
|
artikel
|
| 152 |
Patient-reported outcomes after cytotoxic chemotherapy in metastatic castration-resistant prostate cancer: A systematic review
|
Colloca, Giuseppe
|
|
2010
|
|
6 |
p. 501-506
6 p.
|
artikel
|
| 153 |
Pediatric sarcomas and related tumors of the head and neck
|
Huh, Winston W.
|
|
2011
|
|
6 |
p. 431-439
9 p.
|
artikel
|
| 154 |
Peroxisome proliferator-activated receptor-γ ligands as cell-cycle modulators
|
Theocharis, Stamos
|
|
2004
|
|
6 |
p. 545-554
10 p.
|
artikel
|
| 155 |
Phenotyping drug disposition in oncology
|
Opdam, Frans L.
|
|
2012
|
|
6 |
p. 715-725
11 p.
|
artikel
|
| 156 |
Poor prognosis Ewing's sarcoma and peripheral primitive neuroectodermal tumours (PNET)
|
Maurel, Joan
|
|
1996
|
|
6 |
p. 425-436
12 p.
|
artikel
|
| 157 |
Prevention of chemotherapy and radiation toxicity with glutamine
|
Savarese, Diane M.F
|
|
2003
|
|
6 |
p. 501-513
13 p.
|
artikel
|
| 158 |
Primary bone osteosarcoma in the pediatric age: State of the art
|
Longhi, Alessandra
|
|
2006
|
|
6 |
p. 423-436
14 p.
|
artikel
|
| 159 |
Primary chemotherapy for early breast cancer
|
Ellis, P.A.
|
|
1996
|
|
6 |
p. 437-450
14 p.
|
artikel
|
| 160 |
Primary mediastinal large B-cell lymphoma
|
Bhatt, Vijaya Raj
|
|
2015
|
|
6 |
p. 476-485
10 p.
|
artikel
|
| 161 |
Profiling clinical cancer research across the Atlantic: A review of research and its characteristics presented at ASCO and ESMO Congresses during the last decade
|
Pentheroudakis, George
|
|
2012
|
|
6 |
p. 560-565
6 p.
|
artikel
|
| 162 |
Psychosocial predictors of health outcomes in colorectal cancer: A comprehensive review
|
Sales, Paulo M.G.
|
|
2014
|
|
6 |
p. 800-809
10 p.
|
artikel
|
| 163 |
Radiotherapy: the last 25 years
|
Russell, N.S.
|
|
1999
|
|
6 |
p. 365-376
12 p.
|
artikel
|
| 164 |
Radiotherapy to patients with artificial cardiac pacemakers
|
Sundar, S.
|
|
2005
|
|
6 |
p. 474-486
13 p.
|
artikel
|
| 165 |
Radiotherapy versus surgery within multimodality protocols for esophageal cancer – A meta-analysis of the randomized trials
|
Pöttgen, Christoph
|
|
2012
|
|
6 |
p. 599-604
6 p.
|
artikel
|
| 166 |
Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy
|
Witkamp, Arjen J
|
|
2001
|
|
6 |
p. 365-374
10 p.
|
artikel
|
| 167 |
Recent advances and current controversies in the management of DCIS of the breast
|
Sakorafas, George H.
|
|
2008
|
|
6 |
p. 483-497
15 p.
|
artikel
|
| 168 |
Recent advances in bone-targeted therapies of metastatic prostate cancer
|
Deng, Xiyun
|
|
2014
|
|
6 |
p. 730-738
9 p.
|
artikel
|
| 169 |
Recent advances in management of small-cell lung cancer
|
Chua, Yu Jo
|
|
2004
|
|
6 |
p. 521-543
23 p.
|
artikel
|
| 170 |
Recombinant human erythropoietin in chemotherapy-associated anemia
|
Cascinu, Stefano
|
|
1995
|
|
6 |
p. 553-564
12 p.
|
artikel
|
| 171 |
Referee list
|
|
|
1998
|
|
6 |
p. 441-
1 p.
|
artikel
|
| 172 |
Referees
|
|
|
2000
|
|
6 |
p. 467-
1 p.
|
artikel
|
| 173 |
Referees
|
|
|
2001
|
|
6 |
p. 407-
1 p.
|
artikel
|
| 174 |
Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines
|
Ronghe, M
|
|
2001
|
|
6 |
p. 327-337
11 p.
|
artikel
|
| 175 |
Retinoids and breast cancer: From basic studies to the clinic and back again
|
Garattini, Enrico
|
|
2014
|
|
6 |
p. 739-749
11 p.
|
artikel
|
| 176 |
Revisiting ovarian cancer preclinical models: Implications for a better management of the disease
|
Ricci, Francesca
|
|
2013
|
|
6 |
p. 561-568
8 p.
|
artikel
|
| 177 |
Salvage radiotherapy increases survival in people with residual disease after chemotherapy for advance diffuse large cell lymphoma
|
Kumar, Ambuj
|
|
2006
|
|
6 |
p. 487-490
4 p.
|
artikel
|
| 178 |
Second-look laparotomy for stage III epithelial ovarian cancer: rationale and current issues
|
Muderspach, Laila
|
|
1995
|
|
6 |
p. 499-511
13 p.
|
artikel
|
| 179 |
Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy
|
Bosch-Barrera, Joaquim
|
|
2015
|
|
6 |
p. 540-546
7 p.
|
artikel
|
| 180 |
Soft tissue sarcoma of the extremities. A multimodality diagnostic and therapeutic approach
|
Ham, S.J.
|
|
1998
|
|
6 |
p. 373-391
19 p.
|
artikel
|
| 181 |
Spontaneous regression of cancer
|
Papac, Rose J.
|
|
1996
|
|
6 |
p. 395-423
29 p.
|
artikel
|
| 182 |
Statin use and mortality in cancer patients: Systematic review and meta-analysis of observational studies
|
Zhong, Shanliang
|
|
2015
|
|
6 |
p. 554-567
14 p.
|
artikel
|
| 183 |
Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors
|
Giaccone, Giuseppe
|
|
2011
|
|
6 |
p. 456-464
9 p.
|
artikel
|
| 184 |
Subject and author index
|
|
|
2000
|
|
6 |
p. i-v
nvt p.
|
artikel
|
| 185 |
Subject Index
|
|
|
2001
|
|
6 |
p. 1-3
3 p.
|
artikel
|
| 186 |
Surgical risk and post-operative complications in older unfit cancer patients
|
Kristjansson, Siri R.
|
|
2009
|
|
6 |
p. 499-502
4 p.
|
artikel
|
| 187 |
Switching to exemestane after 2–3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen
|
Davies, Christina
|
|
2004
|
|
6 |
p. 583-588
6 p.
|
artikel
|
| 188 |
Systematic review and meta-analysis of comparative studies reporting early outcomes after robot-assisted radical cystectomy versus open radical cystectomy
|
Li, Kaiwen
|
|
2013
|
|
6 |
p. 551-560
10 p.
|
artikel
|
| 189 |
Systemic chemotherapy in locally advanced and/or metastatic bladder cancer
|
Pectasides, D.
|
|
2006
|
|
6 |
p. 456-470
15 p.
|
artikel
|
| 190 |
Systemic therapy for disseminated basal cell carcinoma: An uncommon manifestation of a common cancer
|
Ganti, Apar Kishor
|
|
2011
|
|
6 |
p. 440-443
4 p.
|
artikel
|
| 191 |
Systemic treatment of AIDS-related Kaposi sarcoma: Current status and perspectives
|
Vanni, Tazio
|
|
2006
|
|
6 |
p. 445-455
11 p.
|
artikel
|
| 192 |
Tamoxifen does not improve overall survival in people with advanced-stage hepatocellular carcinoma
|
Chow, Pierce K.
|
|
2005
|
|
6 |
p. 491-495
5 p.
|
artikel
|
| 193 |
Targeted agents in non-small cell lung cancer (NSCLC): Clinical developments and rationale for the combination with thoracic radiotherapy
|
Koh, Pek Keng
|
|
2012
|
|
6 |
p. 626-640
15 p.
|
artikel
|
| 194 |
Targeted therapy in metastatic colorectal cancer – An example of personalised medicine in action
|
Heinemann, V.
|
|
2013
|
|
6 |
p. 592-601
10 p.
|
artikel
|
| 195 |
Targeting uPA/uPAR in prostate cancer
|
Li, Y.
|
|
2007
|
|
6 |
p. 521-527
7 p.
|
artikel
|
| 196 |
TCTP as therapeutic target in cancers
|
Acunzo, Julie
|
|
2014
|
|
6 |
p. 760-769
10 p.
|
artikel
|
| 197 |
The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant
|
Reynders, Kobe
|
|
2015
|
|
6 |
p. 503-510
8 p.
|
artikel
|
| 198 |
The anthrapyrazoles
|
Gogas, H.
|
|
1995
|
|
6 |
p. 541-552
12 p.
|
artikel
|
| 199 |
The anti-tumour activity of bisphosphonates
|
Neville-Webbe, H.L
|
|
2002
|
|
6 |
p. 305-319
15 p.
|
artikel
|
| 200 |
The blood-brain barrier and oncology: new insights into function and modulation
|
Bart, J.
|
|
2000
|
|
6 |
p. 449-462
14 p.
|
artikel
|
| 201 |
The comparative clinical pharmacology of vincristine and vindesine: Does vindesine offer any advantage in clinical use?
|
Joel, Simon
|
|
1995
|
|
6 |
p. 513-525
13 p.
|
artikel
|
| 202 |
The cost-effectiveness of particle therapy in non-small cell lung cancer: Exploring decision uncertainty and areas for future research
|
Grutters, Janneke P.C.
|
|
2010
|
|
6 |
p. 468-476
9 p.
|
artikel
|
| 203 |
The economic burden of metastatic breast cancer: A systematic review of literature from developed countries
|
Foster, Talia S.
|
|
2011
|
|
6 |
p. 405-415
11 p.
|
artikel
|
| 204 |
The established and future biomarkers of malignant pleural mesothelioma
|
Panou, V.
|
|
2015
|
|
6 |
p. 486-495
10 p.
|
artikel
|
| 205 |
The impact of pharmacogenetics on radiation therapy outcome in cancer patients. A focus on DNA damage response genes
|
Borchiellini, Delphine
|
|
2012
|
|
6 |
p. 737-759
23 p.
|
artikel
|
| 206 |
The management of brain metastases
|
Patchell, Roy A
|
|
2003
|
|
6 |
p. 533-540
8 p.
|
artikel
|
| 207 |
The pregnant mother with breast cancer: Diagnostic and therapeutic management
|
Pavlidis, Nicholas
|
|
2005
|
|
6 |
p. 439-447
9 p.
|
artikel
|
| 208 |
Therapeutic approaches to myeloma bone disease: An evolving story
|
Longo, Vito
|
|
2012
|
|
6 |
p. 787-797
11 p.
|
artikel
|
| 209 |
The role of pentoxifylline as a modifier of radiation therapy
|
Nieder, Carsten
|
|
2005
|
|
6 |
p. 448-455
8 p.
|
artikel
|
| 210 |
The systemic treatment of AIDS-related Kaposi's sarcoma
|
Schwartsmann, G.
|
|
1998
|
|
6 |
p. 415-424
10 p.
|
artikel
|
| 211 |
The treatment of brain metastases in melanoma patients
|
Bafaloukos, D.
|
|
2004
|
|
6 |
p. 515-520
6 p.
|
artikel
|
| 212 |
Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy
|
Balduzzi, Alessandra
|
|
2010
|
|
6 |
p. 443-450
8 p.
|
artikel
|
| 213 |
Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies
|
Amir, Eitan
|
|
2012
|
|
6 |
p. 708-714
7 p.
|
artikel
|
| 214 |
Tolerability and safety of rituximab (MabThera®)
|
Kimby, Eva
|
|
2005
|
|
6 |
p. 456-473
18 p.
|
artikel
|
| 215 |
Towards a simple objective framework for the investigation and treatment of cancer cachexia: The Glasgow Prognostic Score
|
Douglas, Euan
|
|
2014
|
|
6 |
p. 685-691
7 p.
|
artikel
|
| 216 |
Transgenic models and cancer treatment
|
Coletta, P.Louise
|
|
1995
|
|
6 |
p. 565-576
12 p.
|
artikel
|
| 217 |
Treatment of cancer-related anemia with epoetin alfa: a review
|
Ferrario, Erminia
|
|
2004
|
|
6 |
p. 563-575
13 p.
|
artikel
|
| 218 |
Treatment of hepatocellular carcinoma (HCC) by intra-arterial infusion of radio-emitter compounds: Trans-arterial radio-embolisation of HCC
|
Andreana, Lorenzo
|
|
2012
|
|
6 |
p. 641-649
9 p.
|
artikel
|
| 219 |
Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: From laboratory bench to bedside
|
de Bree, Eelco
|
|
2006
|
|
6 |
p. 471-482
12 p.
|
artikel
|
| 220 |
Treatment of prostate cancer in unfit senior adult patients
|
Falci, Cristina
|
|
2009
|
|
6 |
p. 522-527
6 p.
|
artikel
|
| 221 |
Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratory
|
Jensen, P.B.
|
|
1999
|
|
6 |
p. 377-386
10 p.
|
artikel
|
| 222 |
Unmet needs and challenges in gastric cancer: The way forward
|
Lordick, Florian
|
|
2014
|
|
6 |
p. 692-700
9 p.
|
artikel
|
Tijdschrift beschrijving